Prøve GULL - Gratis
PLI boost: Cancer drugs to cost less
Mint Hyderabad
|March 05, 2025
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS―the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR).
The PLI scheme is a "great boon" as cancer drugs will not only become cheaper in India, but South American and southern African nations will also benefit, said Shyam Aggarwal, chairperson, medical oncology department at Sir Ganga Ram Hospital, Delhi.
Denne historien er fra March 05, 2025-utgaven av Mint Hyderabad.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Hyderabad
Mint Hyderabad
Eat, see, dance and repeat
A Mint guide to what's happening in and around your city
1 min
January 09, 2026
Mint Hyderabad
Venezuela’s oil shake-up could go either way for India
The unfolding crisis in Venezuela draws into sharp relief a less-recognized feature of the modern global economy: the movement of expectations often matters more than that of physical goods.
3 mins
January 09, 2026
Mint Hyderabad
Why do human lives remain so undervalued in India?
At first glance, this may seem like a question for economists and statisticians, a matter of compensation data, actuarial logic and policy benchmarks.
3 mins
January 09, 2026
Mint Hyderabad
Budget may propose fix for flaws in debt recovery framework
borrower consent, the people said on condition of anonymity.
3 mins
January 09, 2026
Mint Hyderabad
INDIA'S NEW CARRIERS' TROUBLED FLIGHT PATH
An investigation into 3 airline hopefuls reveals a trail of compliance issues, court convictions and capital shortfall
5 mins
January 09, 2026
Mint Hyderabad
Facebook leases space at Hitec City, Hyderabad
Facebook India Online Services, the local entity of social networking firm Meta, expanded its presence in Hyderabad, with a new five-year lease for 69,702 sq ft of office space in Hitec City, one of the prime information technology corridors in the city
1 min
January 09, 2026
Mint Hyderabad
New SIF compliance reporting format
AMCs managing SIFs will now have to report additional compliance details.
1 min
January 09, 2026
Mint Hyderabad
THE DEPRECIATING RUPEE AND WHAT IT MEANS FOR YOUR INVESTMENT PORTFOLIO
Rupee’s slide to the ‘nervous nineties’ rattled investors, even as RBI stepped in to pull it back
3 mins
January 09, 2026
Mint Hyderabad
NSE, IGX in talks for gas futures contracts
India's National Stock Exchange is in discussions with Indian Gas Exchange, or IGX, to develop and launch Indian natural gas futures, the country’s largest bourse said on Thursday.
1 min
January 09, 2026
Mint Hyderabad
LIC MF banks on agents for a comeback
Unlike private asset management companies’ offices, which often have a sleek, minimalist aesthetic, LIC Mutual Fund’s workspace looks exactly like you'd expect of a government-owned entity—drab furniture and yellow walls.
2 mins
January 09, 2026
Listen
Translate
Change font size